NCT04033718Completed
Inpatient Package to Reduce HIV and AIDS-related Death in Zambia
Source: ClinicalTrials.gov · Last updated 9 Aug 2024
Brief summary (registry, in English)
Early post-discharge mortality is high among HIV-infected Zambians admitted to the hospital. Likely this is in part due to missed opportunities to identify lethal coinfections and optimize HIV care during admission (and before discharge). In this study the investigators will develop and pilot a new approach to inpatient HIV care that follows international guidelines for management of advanced HIV disease.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 23 Jul 2019
- Start date
- 1 Oct 2021
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Tuberculosis, HIV
- NCT number
- NCT04033718
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 1 Oct 2021 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Too sick to provide informed consent (based on clinician opinion)
- Likely to be discharged in the next 48 hours (based on clinician opinion)
Who the study is looking for
- 18+ years old
- HIV-positive (by self-report or DCT result in UTH file)
- Resident of Lusaka
- Admitted to the hospital
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Teaching Hospital Coordinator of this site? Confirm its status | Lusaka | Zambia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.